Author

K. Huey-Tubman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Assay:structural biology· 1

Frequent Co-Authors

C. Gaebler· 3 shared F. Muecksch· 3 shared F. Schmidt· 3 shared M. Caskey· 3 shared S. Finkin· 3 shared T. Hatziioannou· 3 shared Y. Weisblum· 3 shared A. Cho· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

C. Gaebler

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintMar 7, 2021

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies

F. Muecksch, Y. Weisblum, C. Barnes…·P. Bieniasz

This study examines how somatic mutations in SARS-CoV-2 antibodies affect their neutralization potency, breadth, and resistance to escape mutations across six antibody lineages.

DOI 10.1101/2021.03.07.434227

proteomicsexperimental assay

𝕏 PostBluesky

ImmunologybioRxivMay 28, 2020

Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies

C. O. Barnes, A. P. West, K. Huey-Tubman…·P. J. Bjorkman

DOI 10.1016/j.cell.2020.06.025

humanstructural biology

𝕏 PostBluesky

ImmunologybioRxivMay 13, 2020

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals

D. F. Robbiani, C. Gaebler, F. Muecksch…·Nuss

The paper analyzes antibody responses in convalescent individuals, finding low neutralizing titers but rare potent RBD-specific antibodies with broad antiviral potential.

DOI 10.1038/s41586-020-2456-9

humanproteomics

𝕏 PostBluesky